Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 06 September 2018


Zavicefta is indicated for the treatment of the following infections in adults:
- Complicated intra-abdominal infection (cIAI)
- Complicated urinary tract infection (cUTI), including pyelonephritis
- Hospital-acquired pneumonia (HAP), including ventilator associated pneumonia (VAP)

Zavicefta is also indicated for the treatment of infections due to aerobic Gram-negative organisms in adult patients with limited treatment options.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more



See information on best practice in solid organ transplantation, and expert discussions on related hot topics.

Load more

Related Content

More information

Category Value
Agency product number EMEA/H/C/004027
Orphan designation No
Date First Approved 24-06-2016
Type Medicinal product subject to restricted medical prescription
Marketing authorisation holder Pfizer Ireland Pharmaceuticals